Current location: Home > Animal Models > Oncology Models > Xenograft Tumor Models > Leukemia Model > HL-60(systemic)

SIDEBAR
Xenograft Tumor Models
Model HL-60(systemic)
Information on Cells and Models

Cell name:

HL-60(systemic)


Other names for the model:

HL 60、HL.60、HL60


Cell information:

HL-60 cells are derived from human promyelocytic acute leukemia cells. These cells have phagocytic activity and chemotactic response, are positive for the oncogene myc, and express complement receptors and FcR. Click to viewMore information.


Model information:

Inoculate the tail vein, and the mouse strain is NOD/SCID. Approximately 7 days after vaccination, the group can be divided into groups, and the administration time after grouping is approximately 28 days.

Quotation
******

* To view this data,Please Login Or Register access

Message
Talk to our experts?

Email: BD@truwaybio.com

Business: +86 185-0139-0702

Technology: +86 137-7300-5709

Website Usage Help: +86 188-6238-7270

Landline: +86 0512-80601059              

Design your Study now?
Frequently Asked Questions
Subscribe to newsletter
Get the latest news and exclusive offers from Truwaybio
Subscription